A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

NCT04965675 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Migraine in Children

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

H. Lundbeck A/S